GAMMA Investing »

Arrivent Biopharma shares owned by GAMMA Investing

Quarter-by-quarter ownership of Arrivent Biopharma (AVBP) shares owned by GAMMA Investing from 13F filings

Historical chart of GAMMA Investing investment in Arrivent Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Arrivent Biopharma held by GAMMA Investing consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrivent Biopharma by GAMMA Investing

Quarter filed Position value Share count Share price at filing
2024-09-30 $588 25 23.52
2024-06-30 $186 10 18.60

More positions owned by GAMMA Investing

Apple Common Stock (AAPL)
Microsoft Corp Common Stock (MSFT)
Nvidia Corporation Common Stock (NVDA)
Amazon Common Stock (AMZN)
Meta Platforms Inc Cl A Common Stock (META)
Jpmorgan Chase Common Stock (JPM)
Broadcom Common Stock (AVGO)
Alphabet Inc Cap Stk Cl A Common Stock (GOOGL)
Eli Lilly Common Stock (LLY)
Ishares Inc Core Msci Emkt Etf (IEMG)
Alphabet Inc Cap Stk Cl C Common Stock (GOOG)
Ishares Tr National Mun Etf Etf (MUB)
Berkshire Hathaway Inc Del Cl B Common Stock (BRK.B)
Visa Inc Com Cl A Common Stock (V)
Home Depot Common Stock (HD)

View all positions for GAMMA Investing

Top funds holding Arrivent Biopharma

Hillhouse Capital Advisors
OrbiMed Advisors
Octagon Capital Advisors
BlackRock
Suvretta Capital Management
Sofinnova Ventures
Novo A/S
General Catalyst Group Management
Sc China Holding
BlackRock
Vanguard Group
Geode Capital Management
Cormorant Asset Management
Perceptive Advisors
Northern Trust

View all funds holding Arrivent Biopharma